Angiotensin II-mediated oxidative stress and procollagen-1 expression in cardiac fibroblasts: blockade by pravastatin and pioglitazone.
about
Mechanism of the inhibitory effect of atorvastatin on endoglin expression induced by transforming growth factor-beta1 in cultured cardiac fibroblastsMechanical stretch via transforming growth factor-β1 activates microRNA208a to regulate endoglin expression in cultured rat cardiac myoblastsScutellarin alleviates interstitial fibrosis and cardiac dysfunction of infarct rats by inhibiting TGFβ1 expression and activation of p38-MAPK and ERK1/2Effects and mechanisms of PPARalpha activator fenofibrate on myocardial remodelling in hypertension.Statins and myocardial remodelling: cell and molecular pathways.Statins, the renin-angiotensin-aldosterone system and hypertension - a tale of another beneficial effect of statins.Cysteine/cystine redox signaling in cardiovascular disease.Metformin inhibits angiotensin II-induced differentiation of cardiac fibroblasts into myofibroblasts.MicroRNA-208a increases myocardial fibrosis via endoglin in volume overloading heart.Diabetes-induced vascular dysfunction involves arginase ICardiac overexpression of metallothionein rescues cold exposure-induced myocardial contractile dysfunction through attenuation of cardiac fibrosis despite cardiomyocyte mechanical anomalies.Sodium tanshinone IIA sulfonate attenuates angiotensin II-induced collagen type I expression in cardiac fibroblasts in vitro.A peptide vaccine targeting angiotensin II attenuates the cardiac dysfunction induced by myocardial infarction.PPARs as therapeutic targets in cardiovascular disease.Potential role of renin-angiotensin system blockade for preventing myocardial ischemia/reperfusion injury and remodeling after myocardial infarction.Interplay between statins and PPARs in improving cardiovascular outcomes: a double-edged sword?Oxidized LDL, LOX-1 and atherosclerosis.Cardiac fibroblast physiology and pathology.Pathophysiology of Myocardial Infarction.Chemical and Physical Approaches to Extend the Replicative and Differentiation Potential of Stem Cells.Oxidative stress and inflammation as central mediators of atrial fibrillation in obesity and diabetesEffect of simvastatin on collagen I deposition in non-infarcted myocardium: role of NF-κB and osteopontin.Blockade of hypoxia-reoxygenation-mediated collagen type I expression and MMP activity by overexpression of TGF-beta1 delivered by AAV in mouse cardiomyocytes.Effects of the PPARgamma activator pioglitazone on p38 MAP kinase and IkappaBalpha in the spinal cord of a transgenic mouse model of amyotrophic lateral sclerosis.MicroRNA-98 inhibits TGF-β1-induced differentiation and collagen production of cardiac fibroblasts by targeting TGFBR1.Angiotensin II mediates urotensin II expression by hypoxia in cultured cardiac fibroblast.Angiotensin II receptor blocker irbesartan attenuates cardiac dysfunction induced by myocardial infarction in the presence of renal failure.MicroRNA-378 suppresses myocardial fibrosis through a paracrine mechanism at the early stage of cardiac hypertrophy following mechanical stress.
P2860
Q28568492-2776B9D2-45CA-4E8A-9032-5BCFE9DBE03DQ28568593-B7FACEC8-5E6E-429D-BC22-F83938973214Q28578104-E1E6CFC2-D420-4672-9C68-56DA636EB2FEQ30406299-06AC131E-C772-4945-86F2-D756FA87A19BQ34196628-E09FEB3A-C5AD-4363-B0F7-5186DD47BDF5Q34429685-D03C22F8-944E-4E01-8A88-1EF8F297D9EDQ34580141-05EFE526-7B78-47DA-8FC7-AED0476FFF4CQ34983872-36D050D2-85F3-4C6D-A2F1-5F20CCC74882Q35083325-60389947-0D85-48DD-9287-D48B4C7D3785Q35906453-16C26E07-D37F-4220-8559-8E827D5012CAQ36084149-2EC71C9F-C674-4F16-B28F-A5B248156128Q37290035-87D2E9F9-B793-4621-998E-998D216E62FFQ37683865-40EE4DC9-9A4B-4799-9A36-514965747C9AQ37790384-166256B4-D060-42D0-B73F-9EF88746B126Q37862927-EFE9BCF3-2E76-4256-8FD6-8E207910CD1AQ37905844-6A3FD73C-204F-47A1-9C9E-F4E458640433Q37938848-8CBC9E33-2758-4C30-A7B9-244E78E7A3F1Q38423895-ACE7AFC0-3034-4DD8-BD7B-FD7645CD39AFQ38596702-03810E56-DBD2-4C6D-9952-EA7781992F28Q38809993-71DC5A21-1856-470C-90E3-F6DC08FDDB0AQ42368137-32ED9051-E1D4-4F26-81F4-3DBD036F6106Q42816496-E284B718-0C27-4A6B-AC9D-4F4C1EAE07C4Q45868980-1BBEE17A-CF55-4D2A-BF9F-CFBAF974403AQ46724078-CFEB2D3F-9D96-42C5-AED7-2250C1E1BFF9Q47957052-3142277D-85E1-402E-88DC-DB6FAD07792AQ54368254-EC82F307-6478-488B-B846-91802F03A75DQ54402246-49D015AA-D946-4102-9BC5-42ED4DFB19CFQ54979858-6FE7B538-8EED-43C4-BC55-32D5D2C914F2
P2860
Angiotensin II-mediated oxidative stress and procollagen-1 expression in cardiac fibroblasts: blockade by pravastatin and pioglitazone.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Angiotensin II-mediated oxidat ...... pravastatin and pioglitazone.
@en
Angiotensin II-mediated oxidat ...... pravastatin and pioglitazone.
@nl
type
label
Angiotensin II-mediated oxidat ...... pravastatin and pioglitazone.
@en
Angiotensin II-mediated oxidat ...... pravastatin and pioglitazone.
@nl
prefLabel
Angiotensin II-mediated oxidat ...... pravastatin and pioglitazone.
@en
Angiotensin II-mediated oxidat ...... pravastatin and pioglitazone.
@nl
P2860
P1476
Angiotensin II-mediated oxidat ...... pravastatin and pioglitazone.
@en
P2093
Jawahar L Mehta
Jiawei Chen
P2860
P304
P356
10.1152/AJPHEART.00341.2006
P577
2006-05-19T00:00:00Z